Ibusuki, Ritsu
Iwama, Eiji http://orcid.org/0000-0001-8252-290X
Shimauchi, Atsushi
Tsutsumi, Hirono
Yoneshima, Yasuto
Tanaka, Kentaro
Okamoto, Isamu
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21K07100)
Article History
Received: 11 September 2023
Accepted: 20 February 2024
First Online: 2 March 2024
Competing interests
: E.I. has received honoraria from Chugai Pharmaceutical and AstraZeneca. K.T. has received honoraria from Chugai Pharmaceutical, AstraZeneca, Ono Pharmaceutical, Bristol-Myers Squibb, Eli Lilly, Takeda Pharmaceutical, Daiichi-Sankyo, and MSD. I.O. has received honoraria and research funding from Chugai Pharmaceutical, AstraZeneca, Ono Pharmaceutical, Taiho Pharmaceutical, MSD, Eli Lilly, Boehringer Ingelheim, and Bristol-Myers Squibb as well as honoraria from Pfizer and research funding from Astellas, Novartis, Takeda Pharmaceutical, Daiichi Sankyo, Haihe Biopharma, and AbbVie. The remaining authors declare no financial or nonfinancial competing interests.